Snapshot from Aug 03, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech scientific breakthrough

Saxiphilin neutralizes saxitoxin in mice

Analysis based on 8 articles · First reported Jul 16, 2026 · Last updated Jul 17, 2026

Sentiment
10
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The discovery of an effective antidote for saxitoxin could reduce public health risks and liability for shellfish industries, potentially lowering insurance costs and boosting consumer confidence. However, as a preclinical study, immediate market impact is limited; commercialization and regulatory approval are years away.

biotechnology public health seafood safety

Researchers at the University of California, San Francisco (UCSF) led by Daniel Minor have discovered that a naturally occurring protein called saxiphilin, found in bullfrogs and other frogs, can neutralize saxitoxin (STX), a potent neurotoxin responsible for paralytic shellfish poisoning (PSP). In a study published July 16 in Nature Communications, saxiphilin acted as a molecular sponge, binding tightly to STX in the bloodstream and preventing it from reaching nerve and muscle cells. In mouse models, saxiphilin prevented poisoning when administered before or alongside STX, and rescued nearly all mice when given after exposure, mimicking real-world scenarios of accidental ingestion. The protein distributed throughout the body, including the brain, heart, and muscles. This discovery closes a century-old scientific mystery initiated by UCSF researcher Hermann Sommer in the 1920s-30s, who observed frog resistance to shellfish poison. Saxiphilin binds multiple STX variants, making it a promising broad-spectrum antidote. The research was funded by the United States — United States Department of Defense and the United States — National Institutes of Health, and involved collaboration with Stanford University chemist Justin Du Bois. Future work aims to engineer smaller versions of saxiphilin for improved protection and to develop faster shellfish testing methods.

80 Daniel Minor led research
60 List of The Bill characters tested saxiphilin
60 Sandra Zakrzewska tested saxiphilin
per
Principal investigator; his leadership in this breakthrough may lead to further research opportunities and recognition.
Importance 100.0 Sentiment 20.0
per
Postdoctoral scholar who tested saxiphilin in mice; key experimental contributor.
Importance 40.0 Sentiment 5.0
per
Postdoctoral scholar who tested saxiphilin in mice; key experimental contributor.
Importance 40.0 Sentiment 5.0
per
Collaborating chemist; his expertise in synthetic chemistry contributed to the approach.
Importance 30.0 Sentiment 10.0
govactor
Funding agency; the research aligns with its interest in countermeasures against chemical threats.
Importance 30.0 Sentiment 5.0
govactor
Funding agency; supports biomedical research with potential public health benefits.
Importance 30.0 Sentiment 5.0
cnt
Country affected by red tide; the research may benefit coastal communities and indigenous populations.
Importance 20.0 Sentiment 5.0
per
Historical UCSF researcher whose early observations on frog resistance were validated by this study.
Importance 20.0 Sentiment 0.0
loc
State where red tide blooms occur; the antidote could improve public health and shellfish safety monitoring.
Importance 20.0 Sentiment 5.0
cnt
Country with coastal indigenous communities at high exposure risk; potential beneficiary of the antidote.
Importance 15.0 Sentiment 5.0
priv
Minor contributor; provided author Anissa Bara, but no significant impact from this event.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.